Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection
Posted by
www.biotecnika.org
Zydus Cadila has received final approval from the United States Food
and Drug Administration (USFDA) to market Fingolimod capsules,
(Gilenya) in the strengths of 0.5 mg, Zydus Cadila, part of Cadila
Healthcare group, said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-fingolimod-capsules-verapamil-hydrochloride-injection/articleshow/78716968.cms
Subscribe to:
Post Comments (Atom)
Post a Comment